Abstract

Editorial

Uterine Fibroid Embolization in time of Covid-19

Nestor Kisilevzky* and John C Lipman

Published: 02 July, 2020 | Volume 3 - Issue 2 | Pages: 079-080

The coronavirus pandemic has caused major changes in society around the world, especially in healthcare systems. Patients with various medical ailments and conditions who were scheduled to undergo elective treatments before the pandemic arrived, wonder now if they still should follow through with it.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001053 Cite this Article Read Full Article PDF

References

  1. Keung JJ, Spies JB, Caridi TM. Uterine artery embolization: A review of current concepts. Best Pract Res Clin Obstet Gynaecol. 2018; 46: 66-73. PubMed: https://pubmed.ncbi.nlm.nih.gov/29128204/
  2. Lee G, Choi S, Kim K, et al. Association Between Changes in Hemoglobin Concentration and Cardiovascular Risks and All-Cause Mortality Among Young Women. J Am Heart Assoc. 2018; 21; 7: e008147. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30369312
  3. Rodriguez-Leor O, Cid-Alvarez B. STEMI care during COVID-19: losing sight of the forest for the trees. JACC Case Reports 2020 (in press). PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177148/
  4. aibudeen A, Makris GC, Elzein A, Wigham A, Patel R, et al. Pain Management Protocols During Uterine Fibroid Embolisation: A Systematic Review of the Evidence. Cardiovasc Intervent Radiol. 2019; 42: 1663-1677. PubMed: https://pubmed.ncbi.nlm.nih.gov/31520113/

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More